Sutezolid (PNU-100480)|CAS 168828-58-8

Cas No.:	168828-58-8
Synonyms:	PNU-100480; U-100480; PF-02341272
SMILES:	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCSCC3)F
Formula:	C₁₆H₂₀FN₃O₃S
M.Wt:	353.41
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

Sutezolid (PNU-100480) is an oxazolidinone antimicrobial being developed for the treatment of tuberculosis.Target: AntibacterialSutezolid is a much-awaited drug candidate for treatment of Mycobacterium tuberculosis. [1] Sutezolid is an oxazolidinone antibiotic currently in development as a treatment forextensively drug-resistant tuberculosis. Sutezolid is a linezolid analog with superior bactericidal activity against Mycobacterium tuberculosis in the hollow fiber, whole blood and mouse models. Like linezolid, it is unaffected by mutations conferring resistance to standard TB drugs. This study of sutezolid is its first in tuberculosis patients.[2]

References:

[1]. Zhu T, et al. Population pharmacokinetic/pharmacodynamic analysis of the bactericidal activities of sutezolid (PNU-100480) and its major metabolite against intracellular Mycobacterium tuberculosis in ex vivo whole-blood cultures ofpatients with pulmonary [2]. Wallis RS, et al. Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis. PLoS One. 2014 Apr 14;9(4):e94462.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101
2018-0101

Cat. No.	Product name	Field of application
DC10109	Q203	Q203 is a promising new clinical candidate for the treatment of tuberculosis.
DC11277	Zoliflodacin(AZD0914)	Zoliflodacin (ETX0914;AZD0914) is a novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor.
DC10733	Sutezolid (PNU-100480)	Sutezolid (PNU-100480) is an oxazolidinone antimicrobial being developed for the treatment of tuberculosis.
DC8032	Solithromycin	Solithromycin is a novel ketolide antibiotic.
DC10441	Relebactam	Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases [ESBLs] and KPC) and class C (AmpC) enzymes.
DC9723	PBTZ169	PBTZ169 is a decaprenyl-phosphoribose-epimerase (DprE1) inhibitor.
DC11273	Murepavadin (POL7080)	Murepavadin is a novel class of highly specific outer membrane protein targeting antibiotic to treat resistant Pseudomonas infections.
DC8928	Minocycline hydrochloride	Minocycline is a tetracycline antibiotic with neuroprotective, antiapoptotic, anti-inflammatory and antimicrobial effects.
DC1057	Fidaxomicin (Dificid)	Fidaxomicin, is an antibiotic that belongs to the class of macrocylic antibiotics.
DC10612	Delpazolid (LCB01-0371)	Delpazolid (LCB01-0371) is a new oxazolidinone with cyclic amidrazone.